Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AQBNASDAQ:LUMONYSE:MRMNASDAQ:XWEL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAQBAquaBounty Technologies$0.80+1.0%$0.76$0.47▼$1.94$3.06M1.22448,336 shs292,715 shsLUMOLumos Pharma$4.34$4.34$1.37▼$4.58$37.54M0.7488,795 shsN/AMRMMEDIROM Healthcare Technologies$1.49-2.0%$1.16$0.34▼$8.39$42.43M0.93702,508 shs19,432 shsXWELXWELL$0.95+5.1%$0.87$0.70▼$2.70$4.76M0.8957,648 shs153,714 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAQBAquaBounty Technologies+1.02%-1.48%-10.83%+40.18%-52.16%LUMOLumos Pharma0.00%0.00%0.00%0.00%+97.27%MRMMEDIROM Healthcare Technologies-1.98%-4.18%-16.02%+247.63%-69.97%XWELXWELL+2.80%+1.59%+10.20%-7.78%-53.21%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAQBAquaBounty Technologies0.8357 of 5 stars0.04.00.00.02.80.00.6LUMOLumos PharmaN/AN/AN/AN/AN/AN/AN/AN/AMRMMEDIROM Healthcare Technologies0.2537 of 5 stars0.03.00.00.00.61.70.0XWELXWELL1.0918 of 5 stars0.05.00.00.02.80.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAQBAquaBounty Technologies 0.00N/AN/AN/ALUMOLumos Pharma 3.00Buy$8.6398.73% UpsideMRMMEDIROM Healthcare Technologies 4.00Strong BuyN/AN/AXWELXWELL 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAQBAquaBounty Technologies$2.47M1.25N/AN/A$4.10 per share0.19LUMOLumos Pharma$2.21M17.02N/AN/A$3.45 per share1.26MRMMEDIROM Healthcare Technologies$8.30B0.01$1.00 per share1.49$0.31 per share4.82XWELXWELL$33.90M0.15N/AN/A$1.47 per share0.65Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAQBAquaBounty Technologies-$149.19M-$19.05N/A∞N/A-5,842.69%-111.70%-85.47%8/5/2025 (Estimated)LUMOLumos Pharma-$34.03M-$4.29N/AN/AN/A-1,583.49%-233.03%-129.88%N/AMRMMEDIROM Healthcare Technologies$820KN/A0.00∞N/AN/AN/AN/AN/AXWELXWELL-$16.85M-$4.02N/A∞N/A-59.20%-178.73%-63.40%8/12/2025 (Estimated)Latest MRM, XWEL, LUMO, and AQB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025XWELXWELLN/A-$1.00N/A-$1.00N/A$7.02 million5/15/2025Q1 2025AQBAquaBounty Technologies-$0.61$0.16+$0.77$0.11$0.20 millionN/A4/15/2025Q4 2024XWELXWELLN/A-$1.55N/A-$1.55N/A$7.47 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAQBAquaBounty TechnologiesN/AN/AN/AN/AN/ALUMOLumos PharmaN/AN/AN/AN/AN/AMRMMEDIROM Healthcare TechnologiesN/AN/AN/AN/AN/AXWELXWELLN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAQBAquaBounty TechnologiesN/A0.540.54LUMOLumos PharmaN/A2.662.66MRMMEDIROM Healthcare TechnologiesN/A0.340.29XWELXWELLN/A1.681.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAQBAquaBounty Technologies8.92%LUMOLumos Pharma33.99%MRMMEDIROM Healthcare TechnologiesN/AXWELXWELL8.67%Insider OwnershipCompanyInsider OwnershipAQBAquaBounty Technologies2.20%LUMOLumos Pharma25.40%MRMMEDIROM Healthcare Technologies40.24%XWELXWELL8.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAQBAquaBounty Technologies1003.87 million3.78 millionNo DataLUMOLumos Pharma308.65 million6.45 millionNot OptionableMRMMEDIROM Healthcare Technologies48028.39 million2.95 millionNot OptionableXWELXWELL3605.26 million4.80 millionNo DataMRM, XWEL, LUMO, and AQB HeadlinesRecent News About These CompaniesXWELL, Inc. Named Official Wellness Spa of the Orlando Magic in New Multiyear PartnershipJune 17, 2025 | quiverquant.comXWELL Named Official Wellness Spa of the Orlando MagicJune 17, 2025 | globenewswire.comXwell Strengthens its Collaboration with Priority PassMay 22, 2025 | insidermonkey.comXWELL, Inc. Expands Wellness Services Partnership with Priority Pass for Enhanced Airport ExperienceMay 22, 2025 | quiverquant.comXpres Spa Elevates the Travel Experience with New Wellness Benefits for Priority Pass MembersMay 22, 2025 | globenewswire.comXWELL, Inc. Reports First Quarter 2025 Results and Expands Wellness OfferingsMay 22, 2025 | nasdaq.comXWELL, Inc.: XWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven WellnessMay 21, 2025 | finanznachrichten.deXWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven WellnessMay 20, 2025 | globenewswire.comXWELL Faces Nasdaq Delisting Risk Over Bid PriceMay 19, 2025 | tipranks.comXWELL Inc. appoints new auditor, cites internal control issuesApril 23, 2025 | investing.comXWELL, Inc. Reports 13% Revenue Growth and Plans Expansion into Wellness Sector with New Brand StrategyApril 15, 2025 | quiverquant.comXWELL Reports Fiscal Year 2024 ResultsApril 15, 2025 | globenewswire.comXWELL shareholders approve incentive plan amendmentApril 13, 2025 | uk.investing.comXWELL Expands Into Medical Spa Market With Strategic AcquisitionsMarch 15, 2025 | nasdaq.comXwell announces plan for strategic investment in medical spasMarch 13, 2025 | markets.businessinsider.comXWELL, Inc. Announces Acquisition Plans for Medical Spas to Expand Wellness and Beauty OfferingsMarch 13, 2025 | quiverquant.comXWELL Announces Plan for Strategic Investment in Medical Spas to Advance Wellness and Beauty OfferingsMarch 13, 2025 | globenewswire.comCentri Names Presenting Companies for Capital Conference at Nasdaq on April 22March 7, 2025 | finance.yahoo.comXWELL, Inc. (XWEL) Stock Price, News, Quote & History - Yahoo FinanceMarch 4, 2025 | finance.yahoo.comXwell files to sell 1.05M shares of common stock for holdersFebruary 8, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMRM, XWEL, LUMO, and AQB Company DescriptionsAquaBounty Technologies NASDAQ:AQB$0.80 +0.01 (+1.02%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$0.78 -0.02 (-2.50%) As of 06/20/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AquaBounty Technologies, Inc., a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.Lumos Pharma NASDAQ:LUMOLumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of products and therapies for people with rare diseases. Its primary product candidate is LUM-201, an oral growth hormone secretagogue ibutamoren, which is in Phase III clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company has a clinical collaboration with Massachusetts General Hospital to evaluate oral LUM-201 in nonalcoholic fatty liver disease. Lumos Pharma, Inc. is headquartered in Austin, Texas.MEDIROM Healthcare Technologies NYSE:MRM$1.49 -0.03 (-1.98%) Closing price 06/20/2025 03:51 PM EasternExtended Trading$1.51 +0.02 (+1.02%) As of 06/20/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, an on-demand health monitoring smartphone application and MOTHER Bracelet for fitness applications; and preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.XWELL NASDAQ:XWEL$0.95 +0.05 (+5.09%) Closing price 06/20/2025 03:59 PM EasternExtended Trading$0.96 +0.01 (+0.54%) As of 06/20/2025 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
